Medtronic's Next-Gen Portable ECMO System VitalFlow Receives CE Mark Approval

Jun 09, 2025 22:15 CST Updated 22:15

Medtronic

Chronic Disease Medical Device and Therapy Developer

Executives of MedtronicGiuseppe Savoja announced on the social media platform LinkedIn that Medtronic's new generationPortable ECMO---VitalFlowHas already obtained CE approval for market release.VitalFlowIs aA configurable single-system ECMO solution for simplicity and performance. This technology allowsBedside care and intra-hospital transport have become seamless, providing doctors and clinicians with a simpler, smarter, and more reliable ECMO experience.

Executive Evaluation

"Major News for Medtronic Europe Cardiovascular Surgery! I am thrilled to announce that we have achieved a milestone in advancing ECMO patient care: VitalFlow has now officially received CE approval for market release!"This is not only a regulatory milestone --- after years of ECMO innovation and exploration, we are taking a crucial step toward achieving full-process closed-loop management for the most critically ill patients in this region."

---Giuseppe Savoja Sr Business Director Western Europe

ECMO (Extracorporeal Membrane Oxygenation) refers to a circuit that directly oxygenates and removes carbon dioxide from the blood through an extracorporeal gas exchange device (commonly known as a membrane oxygenator).Most commonly used for life-threatening heart failure or lung failure to allow the heart and/or lungs to rest and heal. It is also used as a bridge option for further treatments such as heart or lung transplantation, heart assist devices, or left ventricular assist devices (LVAD).

Traditional ECMO systems are bulky and generally can only be used bedside. Transporting them within hospital wards, operating rooms, or other areas is an extremely challenging task.VitalFlowMake ECMO a mobile, portable life-saving device that can be moved from the ward to the operating room or anywhere in the hospital as needed for clinical use.VitalFlowSimplicity and portability address critical clinical needs.

VitalFlow

VitalFlowOriginated from the acquisition of MC3 Cardiopulmonary in March last year.MC3 CardiopulmonarY is an innovative medical device company established in 1991. It is currently one of the global leaders in the ECMO field.Compared with products from Getinge Group, LivaNova, and other companies, the biggest advantage of ECMO products lies in their simplicity, compact design, and ease of use.

Previously, Medtronic's ECMO products were all produced byMC3 Cardiopulmonary provided, eight years agoMedtronic ObtainsMC3 CardiopulmonarGlobal Exclusive of y ProductDistributionRights. Medtronic's current ECMO series products on sale:NAUTILUS、CRESCENTCatheterAll are derived fromMC3 Cardiopulmonary。

VitalFlowMedtronic andMC3 Cardiopulmonary: The Most Disruptive ECMO Product in Eight Years of Collaboration.

VitalFlowDesign Concept andMC3 CardiopulmonarLike the previous product, it adopts a simple and miniaturized design. According to the public information disclosed by Medtronic:

VitalFlow is a configurable single-system extracorporeal membrane oxygenation (ECMO) system designed to provide a simple design and high-performance ECMO product.VitalFlow AdoptedA large intuitive touchscreen that consolidates real-time performance data and provides configurability,And adopts the verified Medtronic Nautilus ECMO oxygenator design, achieving long-term stable high performance.

Medtronic described it asBridging the Gap Between Bedside Care and Intra-Hospital Transport. The goal is to provide physicians and clinicians with a simpler, smarter extracorporeal membrane oxygenation experience.Addressed the long-neglected true clinical needs in practice.

Medtronic

MedtronicCompleteEstablished in 1949, Medtronic, plc.Headquartered in Minneapolis, Minnesota, USA, is the world's largest medical technology company, committed to providing lifelong treatment solutions for patients with chronic diseases.Medtronic's main products cover arrhythmia, heart failure, vascular diseases, heart valve replacement, extracorporeal heart support, minimally invasive heart surgery, malignant and non-malignant pain, movement disorders, diabetes, gastrointestinal diseases, urinary system diseases,Spinal diseases, neurological disorders, and surgeries in ophthalmology, otolaryngology, and other related fields.